|
1
|
Alzahabi KH, Usmani O, Georgiou TK, Ryan
MP, Robertson BD, Tetley TD and Porter AE: Approaches to treating
tuberculosis by encapsulating metal ions and anti-mycobacterial
drugs utilizing nano- and microparticle technologies. Emerg Top
Life Sci. 4:581–600. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Harding E: WHO global progress report on
tuberculosis elimination. Lancet Respir Med. 8:30418–7. 2020.
View Article : Google Scholar
|
|
3
|
Koch A and Mizrahi V: Mycobacterium
tuberculosis. Trends Microbiol. 26:555–556. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Leopold Wager CM, Arnett E and Schlesinger
LS: Mycobacterium tuberculosis and macrophage nuclear receptors:
What we do and don't know. Tuberculosis (Edinb). Apr 25–2019.(Epub
ahead of print). doi: 10.1016/j.tube.2019.04.016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Correia de Sousa M, Gjorgjieva M, Dolicka
D, Sobolewski C and Foti M: Deciphering miRNAs' Action through
miRNA Editing. Int J Mol Sci. 20:62492019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang X, Zhu M and Hu X: Integrated miRNA
and mRNA expression profiling to identify mRNA targets of
dysregulated miRNAs in pulmonary tuberculosis. Epigenomics.
10:1051–1069. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fu B, Xue W, Zhang H, Zhang R, Feldman K,
Zhao Q, Zhang S, Shi L, Pavani KC, Nian W, et al: MicroRNA-325-3p
facilitates immune escape of Mycobacterium tuberculosis through
targeting LNX1 via NEK6 accumulation to promote anti-apoptotic
STAT3 signaling. mBio. 11:00557–20. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sahu SK, Kumar M, Chakraborty S, Banerjee
SK, Kumar R, Gupta P, Jana K, Gupta UD, Ghosh Z, Kundu M and Basu
J: MicroRNA 26a (miR-26a)/KLF4 and CREB-C/EBPβ regulate innate
immune signaling, the polarization of macrophages and the
trafficking of Mycobacterium tuberculosis to lysosomes during
infection. PLoS Pathog. 13:e10064102017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Niu W, Sun B, Li M, Cui J, Huang J and
Zhang L: TLR-4/microRNA-125a/NF-κB signaling modulates the immune
response to Mycobacterium tuberculosis infection. Cell Cycle.
17:1931–1945. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen LY, Zuraw BL, Liu FT, Huang S and Pan
ZK: IL-1 receptor-associated kinase and low molecular weight GTPase
RhoA signal molecules are required for bacterial
lipopolysaccharide-induced cytokine gene transcription. J Immunol.
169:3934–3939. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shimizu S, Tahara M, Ogata S, Hashimoto K,
Morishige K, Tasaka K and Murata Y: Involvement of nuclear
factor-kB activation through RhoA/Rho-kinase pathway in LPS-induced
IL-8 production in human cervical stromal cells. Mol Hum Reprod.
13:181–187. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang ZH, Zhu D, Xie S, Deng Y, Pan Y, Ren
J and Liu HG: Inhibition of Rho-kinase attenuates left ventricular
remodeling caused by chronic intermittent hypoxia in rats via
suppressing myocardial inflammation and apoptosis. J Cardiovasc
Pharmacol. 70:102–109. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Juarez E, Nuñez C, Sada E, Ellner JJ,
Schwander SK and Torres M: Differential expression of Toll-like
receptors on human alveolar macrophages and autologous peripheral
monocytes. Respir Res. 11:1465–9921. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Guo H, Zhang Y, Cheng BC, Fu X, Zhu P,
Chen J, Chan Y, Yin C, Wang Y, Hossen M, et al: An ethanolic
extract of the aerial part of Siegesbeckia orientalis L. inhibits
the production of inflammatory mediators regulated by AP-1, NF-κB
and IRF3 in LPS-stimulated RAW 264.7 cells. Biosci Trends.
12:330–337. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sierra-Mondragon E, Molina-Jijon E,
Namorado-Tonix C, Rodríguez-Muñoz R, Pedraza-Chaverri J and Reyes
JL: All-trans retinoic acid ameliorates inflammatory response
mediated by TLR4/NF-κB during initiation of diabetic nephropathy. J
Nutr Biochem. 60:47–60. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Korbel DS, Schneider BE and Schaible UE:
Innate immunity in tuberculosis: Myths and truth. Microbes Infect.
10:995–1004. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sharma N, Verma R, Kumawat KL, Basu A and
Singh SK: miR-146a suppresses cellular immune response during
Japanese encephalitis virus JaOArS982 strain infection in human
microglial cells. J Neuroinflammation. 12:302015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pachathundikandi SK and Backert S:
Helicobacter pylori controls NLRP3 expression by regulating
hsa-miR-223-3p and IL-10 in cultured and primary human immune
cells. Innate Immun. 24:11–23. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yu T, Ju Z, Luo M, Hu R, Teng Y, Xie L,
Zhong C, Chen L, Hou W, Xiong Y and Feng Y: Elevated expression of
miR-146a correlates with high levels of immune cell exhaustion
markers and suppresses cellular immune function in chronic
HIV-1-infected patients. Sci Rep. 9:188292019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cui J, Li Z, Cui K, Gao Y, Zhang B, Niu J
and Wang Y: MicroRNA-20a-3p regulates the host immune response to
facilitate the Mycobacterium tuberculosis infection by targeting
IKKβ/NF-κB pathway. Int Immunopharmacol. 91:1072862021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jin H, Yu M, Lin Y, Hou B, Wu Z, Li Z and
Sun J: MiR-502-3P suppresses cell proliferation, migration, and
invasion in hepatocellular carcinoma by targeting SET. Onco Targets
Ther. 9:3281–3289. 2016.PubMed/NCBI
|
|
23
|
Zhang J, Hou L, Liang R, Chen X, Zhang R,
Chen W and Zhu J: CircDLST promotes the tumorigenesis and
metastasis of gastric cancer by sponging miR-502-5p and activating
the NRAS/MEK1/ERK1/2 signaling. Mol Cancer. 18:802019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Specjalski K, Maciejewska A, Pawłowski R,
Chełmińska M and Jassem E: Changes in the expression of microRNA in
the buildup phase of wasp venom immunotherapy: A pilot study. Int
Arch Allergy Immunol. 170:97–100. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lv J, He X, Wang H, Wang Z, Kelly GT, Wang
X, Chen Y, Wang T and Qian Z: TLR4-NOX2 axis regulates the
phagocytosis and killing of Mycobacterium tuberculosis by
macrophages. BMC Pulm Med. 17:1942017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shi L, Jiang Q, Bushkin Y, Subbian S and
Tyagi S: Biphasic dynamics of macrophage immunometabolism during
Mycobacterium tuberculosis infection. mBio. 10:e02550–18. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li X, Huang S, Yu T, Liang G, Liu H, Pu D
and Peng N: MIR-140 modulates the inflammatory responses of
Mycobacterium tuberculosis-infected macrophages by targeting TRAF6.
J Cell Mol Med. 23:5642–5653. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gu X, Gao Y, Mu DG and Fu EQ: MiR-23a-5p
modulates mycobacterial survival and autophagy during Mycobacterium
tuberculosis infection through TLR2/MyD88/NF-κB pathway by
targeting TLR2. Exp Cell Res. 354:71–77. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhao Z, Hao J, Li X, Chen Y and Qi X:
MiR-21-5p regulates mycobacterial survival and inflammatory
responses by targeting Bcl-2 and TLR4 in Mycobacterium
tuberculosis-infected macrophages. FEBS Lett. 593:1326–1335. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu HY: Down-regulation of miR-144 after
Mycobacterium tuberculosis infection promotes inflammatory factor
secretion from macrophages through the Tpl2/ERK pathway. Cell Mol
Biol. 62:87–93. 2016.PubMed/NCBI
|
|
31
|
Gong J, Guan L, Tian P, Li C and Zhang Y:
Rho kinase type 1 (ROCK1) promotes lipopolysaccharide-induced
inflammation in corneal epithelial cells by activating toll-like
receptor 4 (TLR4)-mediated signaling. Med Sci Monit. 24:3514–3523.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chopra P, Koduri H, Singh R, Koul A,
Ghildiyal M, Sharma K, Tyagi AK and Singh Y: Nucleoside diphosphate
kinase of Mycobacterium tuberculosis acts as GTPase-activating
protein for Rho-GTPases. FEBS Lett. 571:212–216. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wu H, Bao Y, Wang L, Li X and Sun J:
Mycobacterium marinum down-regulates miR-148a in macrophages in an
EsxA-dependent manner. Int Immunopharmacol. 73:41–48. 2019.
View Article : Google Scholar : PubMed/NCBI
|
